Cargando…

Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease

Key factors contributing to early stages of atherosclerosis and plaque development include the pro-inflammatory cytokines Interferon (IFN)α, IFNγ and Interleukin (IL)-6 and Toll-like receptor 4 (TLR4) stimuli. Together, they trigger activation of Signal Transducer and Activator of Transcription (STA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szelag, Malgorzata, Piaszyk-Borychowska, Anna, Plens-Galaska, Martyna, Wesoly, Joanna, Bluyssen, Hans A.R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217051/ https://www.ncbi.nlm.nih.gov/pubmed/27166190 http://dx.doi.org/10.18632/oncotarget.9195

Ejemplares similares

Direct Inhibition of IRF-Dependent Transcriptional Regulatory Mechanisms Associated With Disease
por: Antonczyk, Aleksandra, et al.
Publicado: (2019)

SINBAD, structural, experimental and clinical characterization of STAT inhibitors and their potential applications
por: Plens-Gałąska, Martyna, et al.
Publicado: (2022)

Genome-Wide Inhibition of Pro-atherogenic Gene Expression by Multi-STAT Targeting Compounds as a Novel Treatment Strategy of CVDs
por: Plens-Galaska, Martyna, et al.
Publicado: (2018)

Signal Integration of IFN-I and IFN-II With TLR4 Involves Sequential Recruitment of STAT1-Complexes and NFκB to Enhance Pro-inflammatory Transcription
por: Piaszyk-Borychowska, Anna, et al.
Publicado: (2019)

Identification of STAT1 and STAT3 Specific Inhibitors Using Comparative Virtual Screening and Docking Validation
por: Szelag, Malgorzata, et al.
Publicado: (2015)

STAT2/IRF9 directs a prolonged ISGF3-like transcriptional response and antiviral activity in the absence of STAT1
por: Blaszczyk, Katarzyna, et al.
Publicado: (2015)

Editorial: STATs and IRFs in Innate Immunity: From Transcriptional Regulators to Therapeutic Targets
por: Lee, Chien-Kuo, et al.
Publicado: (2019)

Data Mining of Atherosclerotic Plaque Transcriptomes Predicts STAT1-Dependent Inflammatory Signal Integration in Vascular Disease
por: Sikorski, Krzysztof, et al.
Publicado: (2014)

Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors
por: Wrzesiński, Tomasz, et al.
Publicado: (2015)

Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy
por: Eskandarian Boroujeni, Mahdi, et al.
Publicado: (2022)

Potential Approaches and Recent Advances in Biomarker Discovery in Clear-Cell Renal Cell Carcinoma
por: Majer, Weronika, et al.
Publicado: (2015)

STAT1 as a central mediator of IFNγ and TLR4 signal integration in vascular dysfunction
por: Sikorski, Krzysztof, et al.
Publicado: (2012)

The epigenetic landscape of clear-cell renal cell carcinoma
por: Kluzek, Katarzyna, et al.
Publicado: (2015)

Time-dependent recruitment of GAF, ISGF3 and IRF1 complexes shapes IFNα and IFNγ-activated transcriptional responses and explains mechanistic and functional overlap
por: Sekrecka, Agata, et al.
Publicado: (2023)

Thyroid cancers of follicular origin in a genomic light: in-depth overview of common and unique molecular marker candidates
por: Pstrąg, Natalia, et al.
Publicado: (2018)

A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses
por: Michalska, Agata, et al.
Publicado: (2018)

STAT2-directed pathogen responses
por: Bluyssen, Hans
Publicado: (2015)

A type I IFN–Flt3 ligand axis augments plasmacytoid dendritic cell development from common lymphoid progenitors
por: Chen, Yi-Ling, et al.
Publicado: (2013)

FUT11 as a potential biomarker of clear cell renal cell carcinoma progression based on meta-analysis of gene expression data
por: Zodro, Elżbieta, et al.
Publicado: (2013)

STAT1-Dependent Signal Integration between IFNγ and TLR4 in Vascular Cells Reflect Pro-Atherogenic Responses in Human Atherosclerosis
por: Chmielewski, Stefan, et al.
Publicado: (2014)

The Molecular Basis of Viral Inhibition of IRF- and STAT-Dependent Immune Responses
por: Chiang, Hao-Sen, et al.
Publicado: (2019)

Identification of lenalidomide resistance pathways in myeloma and targeted resensitization using cereblon replacement, inhibition of STAT3 or targeting of IRF4
por: Zhu, Yuan Xiao, et al.
Publicado: (2019)

Intracellular expression of IRF9 Stat fusion protein overcomes the defective Jak-Stat signaling and inhibits HCV RNA replication
por: Poat, Bret, et al.
Publicado: (2010)

Properties of STAT1 and IRF1 enhancers and the influence of SNPs
por: Abou El Hassan, Mohamed, et al.
Publicado: (2017)

Identification of RCC Subtype-Specific microRNAs–Meta-Analysis of High-Throughput RCC Tumor microRNA Expression Data
por: Kajdasz, Arkadiusz, et al.
Publicado: (2021)

Targeted inhibition of STAT3 as a potential treatment strategy for atherosclerosis
por: Chen, Qi, et al.
Publicado: (2019)

Regulatory Networks Involving STATs, IRFs, and NFκB in Inflammation
por: Platanitis, Ekaterini, et al.
Publicado: (2018)

Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNA
por: Kluzek, Katarzyna, et al.
Publicado: (2017)

SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis
por: Yoo, Ji-Seung, et al.
Publicado: (2021)

Cell fate in antiviral response arises in the crosstalk of IRF, NF-κB and JAK/STAT pathways
por: Czerkies, Maciej, et al.
Publicado: (2018)

Interferons and IRF/Stat transcription factors in the regulation of immunity, oncogenesis and bone remodeling
por: Taniguchi, T, et al.
Publicado: (2003)

IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
por: Cheon, HyeonJoo, et al.
Publicado: (2013)

Sustained Inflammatory Signalling through Stat1/Stat2/IRF9 Is Associated with Amoeboid Phenotype of Melanoma Cells
por: Gandalovičová, Aneta, et al.
Publicado: (2020)

Inhibition of IRF5 cellular activity with cell-penetrating peptides that target homodimerization
por: Banga, Jaspreet, et al.
Publicado: (2020)

Activation of IFN-γ/STAT/IRF-1 in Hepatic Responses to Klebsiella pneumoniae Infection
por: Lin, Yi-Chun, et al.
Publicado: (2013)

IRF4 Mediates the Oncogenic Effects of STAT3 in Anaplastic Large Cell Lymphomas
por: Bandini, Cecilia, et al.
Publicado: (2018)

ESR Method in Monitoring of Nanoparticle Endocytosis in Cancer Cells
por: Krzyminiewski, Ryszard, et al.
Publicado: (2020)

Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
por: Conery, Andrew R, et al.
Publicado: (2016)

Structural and functional characterization of salmon STAT1, STAT2 and IRF9 homologs sheds light on interferon signaling in teleosts
por: Sobhkhez, Mehrdad, et al.
Publicado: (2014)

MAPK phosphatase 5 inhibits IRF3
por: Png, Chin Wen, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_a67euomsur5b3apn629re5e1jg